欢迎来到《四川大学学报(医学版)》 2025年4月3日 星期四

2型糖尿病患者血糖波动与颈动脉内膜中层厚度的关系

杨晓洁, 何华, 吕霞飞, 文晓蓉, 王椿, 陈大伟, 李秀钧, 冉兴无

杨晓洁, 何华, 吕霞飞, 等. 2型糖尿病患者血糖波动与颈动脉内膜中层厚度的关系[J]. 四川大学学报(医学版), 2012, 43(5): 734-738.
引用本文: 杨晓洁, 何华, 吕霞飞, 等. 2型糖尿病患者血糖波动与颈动脉内膜中层厚度的关系[J]. 四川大学学报(医学版), 2012, 43(5): 734-738.
YANG Xiao-jie, HE Hua, LU Xia-fei, et al. Association of Glycaemic Variability and Carotid Intima-media Thickness in Patients with Type 2 Diabetes Mellitus[J]. Journal of Sichuan University (Medical Sciences), 2012, 43(5): 734-738.
Citation: YANG Xiao-jie, HE Hua, LU Xia-fei, et al. Association of Glycaemic Variability and Carotid Intima-media Thickness in Patients with Type 2 Diabetes Mellitus[J]. Journal of Sichuan University (Medical Sciences), 2012, 43(5): 734-738.

栏目: 糖尿病外周外周血管病变及足病

2型糖尿病患者血糖波动与颈动脉内膜中层厚度的关系

基金项目: 

四川省科技厅科技支撑项目(No.2011sz0220)资助

Association of Glycaemic Variability and Carotid Intima-media Thickness in Patients with Type 2 Diabetes Mellitus

  • 摘要: 目的 探讨2型糖尿病(T2DM)患者血糖波动与颈动脉内膜中层厚度(CIMT)的关系。 方法 连续纳入2009年7月至2012年3月在我院内分泌科住院的T2DM患者64例,所有患者均应用高分辨彩色多谱勒超声诊断仪测定CIMT以及动态血糖监测系统(CGMS)进行72 h血糖监测,并检测糖化血红蛋白(HbA1c)、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-c)、低密度脂蛋白胆固醇(LDL-c)等。根据CIMT<0.9 mm将患者分为CIMT正常组(A组,n=37)和CIMT增厚组(B组,n=27)。 结果 ①A组患者年龄、收缩压、LN(LDL-c)、LN[日间血糖平均绝对差(MODD)]均小于B组,差异有统计学意义(P均<0.05);但两组患者性别、糖尿病病程、体质量指数(BMI)、糖尿病慢性并发症、糖尿病家族史、舒张压、TG、TC、HDL-c以及日内血糖波动指标平均血糖的标准差(SD)与平均血糖波动幅度(MAGE)无明显差异(P>0.05)。②Pearson相关分析显示:糖尿病患者CIMT与年龄、LN(LDL-c)、LN(MODD)、SD相关,r值分别为:0.370(P=0.005)、0.325(P=0.009)、0.346(P=0.005)、0.251(P=0.045)。③多重线性回归分析显示:患者年龄、吸烟、LN(LDL-c)、LN(MODD)是CIMT的重要危险因素。 结论 T2DM患者血糖波动是导致动脉粥样硬化的重要危险因素,且独立于HbA1c之外。

     

    Abstract: Objective To investigate the relationship between blood glucose fluctuations and carotid intima-media thickness (CIMT) in type 2 diabetic patients. Methods 64 patients with type 2 diabetes mellitus (T2DM) in the Department of Endocrinology and Metabolism, West China Hospital from July 2009 to March 2012 were recruited in this study. The CIMT were measured bilaterally with high-resolution ultrasonography. The glucose excursions were assessed by the following parameters obtained from the continuous glucose monitoring system (CGMS) for 72 h:mean blood glucose (MBG) and its standard deviation (SD), mean amplitude of glycemic excursion (MAGE), mean of daily differences (MODD). Glycosylated hemoglobin (HbA1c), triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c) of the participants were also determined. According to the levels of CIMT, 64 diabetic patients were classified into two groups:diabetes mellitus without atherosclerosis (A group, n=37) and diabetes mellitus with atherosclerosis (B group, n=27). The relationship between the parameters of glycaemic variability and CIMT was examined. Results ①There were no differences between A group and B group with regard to gender composition, course of diabetes, body mass index (BMI), diabetic chronic complications, family history of diabetes, smoking, alcohol drinking, diastolic blood pressure (DBP), TG, TC, HDL-c, SD and MAGE (P>0.05). A group had younger age and lower levels of systolic blood pressure (SBP), LN(LDL-c) and LN (MODD) than B group (P<0.05). ②Pearson correlation analyses showed that CIMT was positively correlated with age (r=0.370, P=0.005), LN(LDL-c) (r=0.325, P=0.009), SD (r=0.251, P=0.045) and LN (MODD) (r=0.346, P=[CM(154.5mm]0.005).③Age, smoking, LN(LDL-c) and LN (MODD) were identified as predictors for CIMT in the multiple linear regression analysis. Conclusion Glucose excursions may contribute to the development of atherosclerosis in patients with type 2 diabetes, which is independent from HbA1c levels.

     

  • [1]

    Piconi L, Quagliaro L, Assaloni R,et al.Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev,2006;22(3):198-203.

    [2]

    Al-Dorzi HM, Tamim HM, Arabi YM.Glycaemic fluctuation predicts mortality in critically ill patients. Anaesth Intensive Care,2010;38(4):695-702.

    [3]

    Zoppini G, Verlato G, Targher G, et al. Variability of body weight, pulse pressure and glycaemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study. Diabetes Metab Res Rev,2008;24(8):624-628.

    [4]

    Zoppini G, Verlato G, Targher G, et al. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes? Nutr Metab Cardiovasc Dis,2009;19(5):334-339.

    [5]

    Karrei K, Koehler C, Hanefeld M, et al. Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening. Diab Vasc Dis Res,2004;1(1):51-52.

    [6]

    Hanefeld M. Postprandial hyperglycaemia:noxious effects on the vessel wall. Int J Clin Pract Suppl,2002;129:45-50.

    [7]

    Kim HJ, Ahn CW, Kang ES, et al. The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients. J Diabetes Complications,2007;21(1):7-12.

    [8]

    Hu Y, Liu W, Huang R, et al. Postchallenge plasma glucose excursions, carotid intima-media thickness, and risk factors for atherosclerosis in Chinese population with type 2 diabetes. Atherosclerosis,2010;210(1):302-306.

    [9]

    Chen XM, Zhang Y, Shen XP, et al.Correlation between glucose fluctuations and carotid intima-media thickness in type 2 diabetes. Diabetes Res Clin Pract,2010;90(1):95-99.

    [10]

    Buscemi S, Re A, Batsis JA, et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes. Diabet Med,2010;27(8):872-878.

    [11]

    Nalysnyk L, Hernandez-Medina M, Krishnarajah G. Glycaemic variability and complications in patients with diabetes mellitus:evidence from a systematic review of the literature. Diabetes Obes Metab,2010;12(4):288-298.

    [12]

    Monnier L, Colette C, Owens DR. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes:a move towards a unified glucose tetrad concept. Diabetes Metab Res Rev,2009;25(5):393-402.

    [13]

    Bots ML, Dijk JM, Oren A, et al.Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease:current evidence. J Hypertens,2002;20(12):2317-2325.

    [14]

    Genuth S, Alberti KG, Bennett P, et al.Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care,2003;26(11):3160-3167.

    [15] 何利平, 王 椿, 钟 莉等. 成都地区糖耐量正常者血糖水平变化的特征分析. 四川大学学报(医学版),2009;40(4):704-707.
    [16] 刘力生, 中国高血压防治指南修订委员会. 中国高血压防治指南2010. 中华高血压杂志,2011;19(8):701-743.
    [17]

    Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC Ⅱ). Eur J Vasc Endovasc Surg,2007;33(Suppl 1):S1-S75.

    [18]

    Mitsuhashi N, Onuma T, Kubo S, et al. Coronary artery disease and carotid artery intima-media thickness in Japanese type 2 diabetic patients. Diabetes Care,2002;25(8):1308-1312.

    [19]

    Casella IB, Sotelo FJ, Yamazaki Y, et al. Comparison of common carotid artery intima-media thickness between Brazilian Euro-descendants and Afro-descendants with atherosclerosis risk factors. Clinics (Sao Paulo),2009;64(7):657-664.

    [20]

    Ghanim H, Aljada A, Hofmeyer D, et al. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation,2004;110(12):1564-1571.

    [21]

    Otsuka A, Azuma K, Iesaki T,et al. Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta. Diabetologia,2005;48(12):2667-2674.

    [22]

    Risso A, Mercuri F, Quagliaro L, et al. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab,2001;281(5):E924-E930.

    [23]

    Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture:the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis,2005;183(2):259-267.

    [24]

    Nathan DM, Cleary PA, Backlund JY, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group.Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med,2005;353(25):2643-2653.

    [25]

    Holman RR, Paul SK, Bethel MA,et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med,2008;359(15):1577-1589.

计量
  • 文章访问数:  2662
  • HTML全文浏览量:  211
  • PDF下载量:  49
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-05-20
  • 修回日期:  2012-07-11
  • 发布日期:  2012-09-19

目录

    /

    返回文章
    返回